Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Diabetes Care|June 16, 2018
Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER ExperienceBernard Zinman, Steven P Marso, Erik Christiansen, et al.
European Heart Journal|December 25, 2004
The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 yearsPernille Buch, Søren Rasmussen, Steen Z Abildstrom, et al.
Plos One|April 17, 2015
Proteomics perspectives in rotator cuff research: a systematic review of gene expression and protein composition in human tendinopathyMaria Hee Jung Sejersen, Poul Frost, Torben Bæk Hansen, et al.
Cardiovascular Diabetology|April 28, 2022
Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6Mansoor Husain, Agostino Consoli, Alessandra De Remigis, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 24, 2010
Prognostic information in administrative co-morbidity data following coronary artery bypass graftingSteen Zabell Abildstrøm, Anders Hvelplund, Søren Rasmussen, et al.
Diabetologia|September 24, 2013
Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover studyGerd Koehler, Simon Heller, Stefan Korsatko, et al.
Diabetes Care|May 30, 2013
Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trialStephen C L Gough, Anuj Bhargava, Rajeev Jain, et al.
Ugeskrift for Laeger|February 23, 2008
[The Danish Heart Registry--a clinical database]Steen Zabell Abildstrøm, Marie Kruse, Søren Rasmussen, et al.
Diabetes, Obesity & Metabolism|February 19, 2021
Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutideSubodh Verma, Udi Fainberg, Mansoor Husain, et al.
International Journal of Cancer|September 10, 2005
Cancer risk among patients with multiple sclerosis: a population-based register studyNete Munk Nielsen, Klaus Rostgaard, Søren Rasmussen, et al.
Pageof 11